NA C315H4002 (UDI 00763000160173)Recalls & reported problems
Medtronic, Inc. · CATH C315H4002 · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00763000160173), received between Aug 23, 2022 and Sep 14, 2022 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Leak/Splash” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Appropriate Device Problem Term/Code Not Available1
- Leak/Splash1
- Use of Device Problem1
Patient problems
- Dizziness1
- Low Blood Pressure/ Hypotension1
- Nausea1
- No Clinical Signs, Symptoms or Conditions1
- Tachycardia1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 14, 2022Leak/Splash; Use of Device Problem; Leak/Splash; Use of Device Problem
IT WAS REPORTED THAT DURING AN IMPLANT PROCEDURE THE USER WAS DISSATISFIED WITH THE INSERTION OF THE LEAD INTO THE CATHETER VALVE. IT WAS NOTED THAT THE CATHETER VALVE WAS LEAKING BLOOD INTO THE LEAD IMPACTING THE TORQUABILITY. THE PATIENT IS A PARTICIPANT IN A CLINICAL STUDY. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15419533 ↗InjuryAug 23, 2022Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available
IT WAS REPORTED THAT THE PATIENT EXPERIENCED SUSTAINED VENTRICULAR TACHYCARDIA (VT) WITH REPORTED DIZZINESS, NAUSEA, AND HYPOTENSION. THE SYMPTOMS WERE SUSPECTED TO BE RELATED TO THE IMPLANT PROCEDURE WHICH THE VENTRICULAR TISSUE COULD HAVE BEEN IRRITATED POSSIBLY BY THE CATHETER. THE CATHETER WAS REMOVED. THE PATIENT IS A PARTICIPANT IN A CLINICAL STUDY. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Dizziness; Low Blood Pressure/ Hypotension; Nausea; Tachycardia
MAUDE report 15276172 ↗
Other Catheter, percutaneous devices
- WATCHMAN FXD Curve™ Access System M635TU80020Boston Scientific Corporation · Catheter, percutaneous1 recall47 deaths654 reports
- NA C315HIS02Medtronic, Inc. · Catheter, percutaneous1 recall369 reports
- WATCHMAN TruSteer™ Access System M635TU90050Boston Scientific Corporation · Catheter, percutaneous1 recall28 deaths302 reports
- Guidezilla™ II H7493933515060Boston Scientific Corporation · CATHETER, PERCUTANEOUS1 recall3 deaths278 reports
- Velocity Delivery Microcatheter VEL160STR-APenumbra, Inc. · CATHETER, PERCUTANEOUS297 reports
- Guidezilla™ H7493924215050Boston Scientific Corporation · CATHETER, PERCUTANEOUS294 reports
- WATCHMAN™ TruSeal™ Access System M635TU70020Boston Scientific Corporation · Catheter, percutaneous1 recall11 deaths217 reports
- Lantern Delivery Catheter PXSLIMLAN135T45Penumbra, Inc. · CATHETER, PERCUTANEOUS220 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page